Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis 1093

Max Ratio

Dividend Yield

0.67 %

5Y Dividend Growth

220.00 %

Consecutive Years

2 years

5Y Average Payout Ratio

5.81 %

Dividend History 1093

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 0.67 %
Consecutive Years 2
Forward Annual Dividend 0.0055 EUR
Consistent Years 2
Dividend CAGR 3Y 5.63 %
Continuous Dividends
Dividend CAGR 5Y 26.20 %
Payout Ratio TTM 3.24 %
Dividend CAGR 10Y 21.81 %
Ex Dividend Date 10/17/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth 1093

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin 1093

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income 1093

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM 1093

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio 1093

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

CSPC Pharmaceutical Group Limited 1093

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself 1093

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 21.39
Forward PE 14.81
Enterprise Value Revenue 2.84
Price Sales TTM 0.39
Enterprise Value EBITDA 14.95
Price Book MRQ 2.44

CSPC Pharmaceutical Group Limited Dividends: 0.39 % Yield, History, Payment Schedule

1093
Current price
7.64 HKD -0.01 HKD (-0.13%)
Last closed 0.83 EUR
ISIN HK1093012172
Sector Healthcare
Industry Drug Manufacturers - General
Exchange Hong Kong Stock Exchange
Capitalization 9 953 515 719 EUR
Yield for 12 month +42.54 %
1Y
3Y
5Y
10Y
15Y
1093
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+3 503 908 130 EUR

Last Year

+3 798 728 937 EUR

Current Quarter

+916 164 848 EUR

Last Quarter

+940 277 453 EUR

Current Year

+2 451 797 571 EUR

Last Year

+2 678 630 425 EUR

Current Quarter

+650 381 931 EUR

Last Quarter

+670 900 432 EUR
EBITDA 5 345 169 695 EUR
Operating Margin TTM 16.98 %
Price to Earnings 21.39
Return On Assets TTM 5.65 %
PEG Ratio 1.35
Return On Equity TTM 10.83 %
Wall Street Target Price
Revenue TTM 25 852 494 799 EUR
Book Value 2.90 EUR
Revenue Per Share TTM
Dividend Share 0.22 EUR
Quarterly Revenue Growth YOY -14.30 %
Dividend Yield 0.67 %
Gross Profit TTM 17 256 971 127 EUR
Earnings per share 0.040 EUR
Diluted Eps TTM 0.040 EUR
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY -21.20 %
Profit Margin 14.83 %

Technical Indicators 1093

For 52 Weeks

0.50 EUR 1.22 EUR
50 Day MA 0.97 EUR
Shares Short Prior Month
200 Day MA 0.84 EUR
Short Ratio
Shares Short
Short Percent